What is it about?
The aim of this study is to compare, in cost-effectiveness and cost-utility terms, a brief transdiagnostic cognitive-behavioural therapy in two different modes, individual and group, with the treatment usually administered in primary care (TAU). Participants between 18 and 65 years old and with, according to the pretreatment evaluation, mild to moderate emotional disorders will be randomly allocated to the three clusters. They will be assessed again immediately after treatment and 6 and 12 months later.
Featured Image
Photo by Lukas Blazek on Unsplash
Read the Original
This page is a summary of: Cost-effectiveness and cost-utility evaluation of the individual vs. group transdiagnostic psychological treatment for emotional disorders in Primary Care(PsicAP-Costs) v2, September 2021, ZappyLab, Inc.,
DOI: 10.17504/protocols.io.bx2npqde.
You can read the full text:
Contributors
The following have contributed to this page
